Effectiveness of an RT-PCR testing protocol for SARS-CoV-2 on the preservation of the health workforce during the COVID-19 pandemic in Brazil: a randomized, parallel group clinical trial
- Funded by Decanato de Pesquisa e Inovação - Universidade de Brasilia (DPI)
- Total publications:2 publications
Grant number: 1004131
Grant search
Key facts
Disease
COVID-19start year
-99Known Financial Commitments (USD)
$161,700.21Funder
Decanato de Pesquisa e Inovação - Universidade de Brasilia (DPI)Principal Investigator
Licia Maria Henrique da MotaResearch Location
BrazilLead Research Institution
N/AResearch Priority Alignment
N/A
Research Category
Infection prevention and control
Research Subcategory
Restriction measures to prevent secondary transmission in communities
Special Interest Tags
N/A
Study Type
Clinical
Clinical Trial Details
Randomized Controlled Trial
Broad Policy Alignment
Pending
Age Group
Adults (18 and older)
Vulnerable Population
Unspecified
Occupations of Interest
Health PersonnelNurses and Nursing StaffPhysicians
Abstract
Introduction: the rapid expansion of the pandemic COVID-19, a disease caused by the new coronavirus SARS-CoV-2, characterized by viral pneumonia, severe in up to 20% of cases, seriously threatens the capacity of health systems to support the explosion in health care demand observed. High transmissibility represents a high occupational risk to the health workforce, which provides assistance to patients. Many health professionals will be infected and will have to leave work, further reducing the health care capacity of already overburdened health systems. Objectives: to evaluate the efficacy of a molecular testing protocol for SARS-CoV-2, for a quick and safe return to the work of health professionals on suspicion of COVID-19, in order to preserve the specialized workforce. Methodology: randomized clinical trial, including health professionals (doctors, physiotherapists, nurses and nursing technicians) from Brazilian University Hospitals, away from work due to suspicion of COVID-19. Participants will be randomized to (1) return to work guided by a defined molecular testing protocol (RT-PCR) for SARS-CoV-2 or (2) usual conduct in the absence of SARS-CoV-2 testing, with removal of the professional by 14 days. Primary outcome: time off work. Secondary outcomes: hospital admissions and deaths due to COVID-19 among health professionals. Calculated sample size: 252 participants. Statistical analyzes: comparison of means by the Student's t test, comparison of frequencies by the chi-square; alpha 0.05. Expected results: the molecular testing protocol will possibly reduce the average time off work for health professionals suspected of COVID-19, allowing early return for those whose SARS-CoV-2 infection has been ruled out. Relevance: the faster replenishment of the workforce will contribute to the relative preservation of the health care capacity of the health system.
Publicationslinked via Europe PMC
Last Updated:an hour ago
View all publications at Europe PMC